Release Date: August 16, 2010
Source: Corporate News Center
Recently, UTop Pharma’s core product has successfully passed the Certificate of Suitability to the European Pharmacopoeia (CEP) certification and officially received the certificate issued by the European Directorate for the Quality of Medicines (EDQM).
This major achievement marks the full alignment of UTop Pharma’s quality management system with international standards, symbolizing a decisive step toward entering the high-end pharmaceutical market of the European Union.
The CEP certification is one of the highest standards for quality and safety management in the European pharmaceutical industry. It signifies that a product’s manufacturing process, quality control, and data management fully comply with the European Pharmacopoeia (Ph. Eur.) requirements.
Renowned for its rigor, long review cycle, and high thresholds, the CEP is often referred to as the “Golden Key” to entering the European pharmaceutical market.
The successful certification of UTop Pharma’s core product demonstrates the company’s achievement of world-class standards in manufacturing quality, risk control, and documentation management.
This milestone lays a solid foundation for expanding into the European and American markets and provides strong technical credibility for future global registrations and collaborations.
Since 2008, UTop Pharma has been advancing the construction of its international quality management system with the goal of achieving “one-time approval in international audits.”
Through systematic enhancements, the company improved the standardization and traceability of every stage of its production process.
During this period, the company implemented several key improvements:
Quality Management System (QMS) Upgrade: Established a framework compliant with ICH Q10, strengthening document control, deviation management, and continuous improvement mechanisms.
Equipment and Process Modernization: Introduced EU-GMP-compliant key equipment, optimized reaction and lyophilization parameters, and enhanced process repeatability and stability.
Data Integrity Enhancement: In line with FDA 21 CFR Part 11, implemented full digitalization and traceability of laboratory and production data, ensuring transparency and verifiability.
Training and Audit Reinforcement: Formed an international audit team of experts in quality, process, and validation to conduct regular internal GMP audits and third-party mock inspections.
These initiatives enabled UTop Pharma to make a remarkable leap within two years—from meeting domestic quality standards to establishing a globally recognized quality certification system.
Throughout the certification process, all departments within the company worked in close coordination—from R&D and production to QA/QC and regulatory affairs—strictly adhering to EDQM requirements.
The R&D team provided detailed process validation reports and impurity profiling data; the quality department implemented a full deviation-tracking system; and the regulatory team ensured all submission documents met EU formatting and linguistic standards.
This systematic, standardized, and scientific collaboration model won high recognition from the reviewing authority.
In its evaluation report, the EDQM audit experts commended UTop Pharma’s outstanding performance in process control, data integrity, and quality culture, affirming its competitiveness on the international stage.
Obtaining the CEP certification is not only a milestone in UTop Pharma’s history but also the starting point for the company’s entry into the upper tiers of the global pharmaceutical supply chain.
Looking ahead, UTop Pharma will leverage this achievement to:
Accelerate international registrations of more core products and expand its presence in Europe and North America;
Deepen the digital transformation of its quality system and build smart manufacturing facilities aligned with international standards;
Strengthen collaborations with overseas pharmaceutical enterprises in the fields of APIs, medical peptides, and lyophilized formulations.
“We firmly believe that quality is the first passport to the global market.”
— Director of Quality Management, UTop Pharma
In 2010, the successful attainment of CEP certification stands as the best reward for UTop Pharma’s long-standing commitment to the principle of “Winning the Future through Quality.”
This honor reflects the high recognition by international authorities of the company’s R&D and manufacturing excellence and further solidifies its brand image as a technology-driven, quality-first enterprise.
Moving forward, UTop Pharma will continue to uphold a spirit of scientific rigor and innovation, driving the advancement of China’s peptide APIs and pharmaceuticals onto the global stage with greater vitality and excellence.
Issued by: Quality Management Center
Editor: Corporate Branding Department
Date of Publication: August 16, 2010
